Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 91.39B | 89.21B | 78.55B | 86.44B | 68.64B | 56.32B |
Gross Profit | 13.05B | 12.90B | 10.74B | 18.15B | 12.93B | 10.80B |
EBITDA | 19.25B | 20.58B | 14.57B | 22.07B | 16.27B | 14.62B |
Net Income | 8.04B | 10.02B | 6.07B | 12.41B | 8.70B | 6.80B |
Balance Sheet | ||||||
Total Assets | 136.21B | 116.19B | 101.96B | 96.38B | 80.55B | 72.49B |
Cash, Cash Equivalents and Short-Term Investments | 7.60B | 7.05B | 4.98B | 12.16B | 8.25B | 5.06B |
Total Debt | 27.38B | 16.51B | 14.58B | 11.19B | 6.16B | 6.15B |
Total Liabilities | 65.59B | 51.18B | 45.54B | 38.05B | 29.67B | 26.85B |
Stockholders Equity | 70.59B | 64.99B | 56.40B | 58.31B | 50.87B | 45.63B |
Cash Flow | ||||||
Free Cash Flow | 3.94B | 2.67B | -3.35B | 6.37B | 7.16B | 4.96B |
Operating Cash Flow | 18.82B | 17.66B | 12.18B | 16.40B | 13.14B | 11.26B |
Investing Cash Flow | -29.27B | -15.00B | -15.54B | -10.07B | -6.00B | -6.30B |
Financing Cash Flow | 11.00B | -590.00M | -3.83B | -2.42B | -3.96B | -1.27B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $2.36B | 148.98 | 1.79% | 0.49% | 5.55% | -79.38% | |
78 Outperform | $45.53B | 8.83 | 13.49% | 7.51% | -12.89% | -46.86% | |
77 Outperform | $134.91B | 15.27 | 19.51% | 4.01% | -7.86% | 14.17% | |
75 Outperform | $106.18B | 9.78 | 18.18% | 5.97% | -0.44% | -4.20% | |
74 Outperform | $10.10B | 12.80 | 11.67% | 1.47% | 15.19% | 4.19% | |
61 Neutral | $10.48B | 7.52 | -0.05% | 2.87% | 2.87% | -36.73% | |
60 Neutral | $11.16B | ― | -9.57% | ― | 39.42% | -172.40% |